Abstract
Introduction Weight loss, consumption of a Dietary Approaches to Stop Hypertension (DASH) dietary pattern, reduced sodium intake, and increased physical activity have been shown to lower blood pressure. Use of web-based tools and telehealth to deliver lifestyle counseling could be potentially scalable solutions to improve blood pressure through behavioral modification though limited data exists to support these approaches in clinical practice.
Methods and analysis This randomized controlled trial will compare the efficacy of a telehealth versus self-directed lifestyle intervention in lowering 24-hour systolic blood pressure in patients with body mass index ≥ 25 kg/m2 and 24-hour SBP 120-160 mmHg. All participants receive personalized recommendations to improve dietary quality based on a web-based food frequency questionnaire, access to an online comprehensive weight management program, and a smartphone dietary app. The telehealth arm additionally includes weekly calls with registered dietitian nutritionists who use motivational interviewing. The primary outcome is change from baseline to 3-months in 24-hour systolic blood pressure. Secondary outcomes include changes from baseline in Healthy Eating Index-2015 score, weight, waist circumference, and physical activity.
Ethics and dissemination The study has been approved by the Geisinger Institutional Review Board. Results will be disseminated through peer-reviewed publications and conference presentations.
Trial registration number ClinicalTrials.gov Identifier NCT03700710
WHO Trial Registration Data Set
Primary registry and trial identifying number: ClinicalTrials.gov Identifier NCT03700710
Date of registration in Primary Registry: 10/9/2018
Secondary identifying numbers: N/A
Source of Monetary or Material Support: Geisinger Health Plan
Primary Sponsor: Geisinger Clinic
Secondary Sponsors: None
Contact for Public Queries: Christina Yule; 570-214-5233; cmyule{at}geisinger.edu
Contact for Scientific Queries: Alex R. Chang, MD, MS; Kidney Health Research Institute; Geisinger; 100 N Academy Ave, Danville, PA; 570-271-8026; achang{at}geisinger.edu
Public title: Remote Dietary Counseling to Promote Healthy Diet and Blood Pressure
Scientific title: Remote Dietary Counseling to Promote Healthy Diet and Blood Pressure
Countries of recruitment: USA
Health conditions studied: high blood pressure
Interventions:
Active Comparator: Self-Guided Approach
In the self-guided arm, participants will receive access to web-based tools to help achieve healthy lifestyle changes to lower their blood pressure. The web-based tools include: 1) a web-based food frequency questionnaire (Viocare FFQ), which will provide a snapshot of participants’ dietary habits in the past 6 months as well as personalized recommendations for areas to improve; 2) access to BMIQ (www.bmiq.com), an evidence-based program developed by Dr. Louis Aronne at Columbia University, which includes program materials for weight loss and leading a healthy lifestyle; 3) LoseIt (www.loseit.com), a meal-logging app that integrates seamlessly with the BMIQ website.
Experimental: Dietitian-led Approach
In the dietitian-led arm, dietitian will use motivational interviewing in 15-30 minute telephone calls with participants. The BMIQ website will be used to share participant dietary data (LoseIt) and weight data with dietitians. Participants will receive access to web-based tools to help achieve healthy lifestyle changes to lower their blood pressure. The web-based tools include: 1) a web-based food frequency questionnaire (Viocare FFQ), which will provide a snapshot of participants’ dietary habits in the past 6 months as well as personalized recommendations for areas to improve; 2) access to BMIQ; 3) LoseIt (www.loseit.com), a meal-logging app that integrates seamlessly with the BMIQ website.
Key Inclusion and Exclusion Criteria
Inclusion Criteria: 24-hour ambulatory SBP 120-160 mmHg, BMI ≥ 25 kg/m2, access to a telephone, access to a computer or smartphone with internet access, complete dietary data entry using LoseIt for at least 5 out of 7 days during run-in period, enter weight into the BMIQ portal during run-in period
Exclusion Criteria: inability to understand English, myocardial infarction, stroke, or atherosclerotic cardiovascular disease procedure within last 6 months, current treatment for malignancy, planned or previous bariatric surgery, pregnant, breast-feeding, or planned pregnancy prior to the end of participation, self-reported average consumption of > 21 alcoholic beverages per week or binge drinking, psychiatric hospitalization in past year, current symptoms of angina, planning to leave the area prior to end of the study, current participation in another clinical trial, principal investigator discretion (i.e. concerns about safety, compliance)
Study type: randomized, parallel-arm, interventional study; study staff assessing outcomes and statistical analysis are masked. Purpose is to compare the efficacy of a self-guided vs. a telehealth dietitian-led approach to lower blood pressure through lifestyle modification.
Date of first enrollment – 1/16/19
Sample size – 200
Recruitment status – recruiting
Primary outcome - Change in 24-hour Systolic Blood Pressure [Time Frame: Baseline to 12-week follow-up] Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Key secondary outcomes
Change in 24-hour diastolic blood pressure [Time Frame: Baseline to 12-week follow-up] Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Daytime Systolic Blood Pressure [Time Frame: Baseline to 12-week follow-up] Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Nighttime Systolic Blood Pressure [Time Frame: Baseline to 12-week follow-up] Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Daytime Diastolic Blood Pressure [Time Frame: Baseline to 12-week follow-up] Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Nighttime Diastolic Blood Pressure [Time Frame: Baseline to 12-week follow-up] Measured by 24-hour ambulatory blood pressure monitoring (SpaceLabs Ontrak)
Change in Total Healthy Eating Index - 2015 score [Time Frame: Baseline to 12-week follow-up] Assessed by Viocare Food Frequency Questionnaire (score 0-100, 100=best possible score) Change in Weight [Time Frame: Baseline to 12-week follow-up] Weight measured at baseline and 12-week visits using a calibrated scale without shoes
Change in Waist Circumference [Time Frame: Baseline to 12-week follow-up] Measured using Gulick II tape measure
Change in Physical Activity (metabolic equivalent of task [MET]-minute per week
[Time Frame: Baseline to 12-week follow-up] Measured by International Physical Activity Questionnaire (IPAQ) Short Form
Change in Clinic systolic blood pressure (SBP) [Time Frame: Baseline to 12-week follow-up]Measured by average of 3 readings using Omron HEM 907XL
Change in Clinic diastolic blood pressure (DBP) [Time Frame: Baseline to 12-week follow-up] Measured by average of 3 readings using Omron HEM 907XL
Ethics review – status approved, date of approval 10/2/2018
Completion date – ongoing
Summary results – N/A
IPD sharing statement – Deidentified data may be shared upon reasonable request.
Strengths and limitations of this study
This randomized controlled trial will compare the efficacy of a telehealth vs. self-directed lifestyle intervention in lowering blood pressure through lifestyle modification in patients with elevated blood pressure and overweight/obesity
The proposed interventions under investigation are low-cost and potentially scalable
Primary endpoint data will be collected using 24-hour ambulatory blood pressure monitoring at baseline and at 3 months
Additional secondary endpoint data will be collected including Healthy Eating Index-2015 score assessed by food frequency questionnaire, weight, waist circumference, and physical activity, assessed by questionnaire
While participants and some of the study staff are unable to be blinded, researchers assessing study outcomes and conducting analyses will be blinded to the arms.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03700710
Funding Statement
This work was supported by Geisinger Health Plan. AC is supported by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases K23DK106515. Funders had no role in the study design, collection, management, analysis, interpretation of data, or the decision to submit the report to publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Initial ethical review and approval for this study was obtained from the Geisinger Institutional Review Board (IRB) on 10/2/2018 (current protocol version 1.22; approved 8/6/2020).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.